1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pregabalin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-21O7531
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pregabalin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pregabalin Market Research Report 2025

Code: QYRE-Auto-21O7531
Report
September 2025
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pregabalin Market

The global market for Pregabalin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. 

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pregabalin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pregabalin.
The Pregabalin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pregabalin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pregabalin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pregabalin Market Report

Report Metric Details
Report Name Pregabalin Market
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ZCL Chemicals, Olon S.p.A., AASraw Biochemical Technology, Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi’s Laboratories, Angels Pharma, ARITE Pharmaceutical, BAL Pharma, Bazayan, Aurobindo Pharma, Hikal, Glenmark Life Sciences, Dongbang FTL, Teva Pharmaceutical Industries, Chemo Iberica, Maps Laboratories, Laurus Labs, Zhejiang Huahai Pharmaceutical, Vasudha Pharma Chem, Sun Pharmaceutical Industries, CTX Life Sciences, Srini Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pregabalin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pregabalin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pregabalin Market report?

Ans: The main players in the Pregabalin Market are ZCL Chemicals, Olon S.p.A., AASraw Biochemical Technology, Changzhou Pharmaceutical Factory (CPF), Almelo Pvt. Ltd., Divi’s Laboratories, Angels Pharma, ARITE Pharmaceutical, BAL Pharma, Bazayan, Aurobindo Pharma, Hikal, Glenmark Life Sciences, Dongbang FTL, Teva Pharmaceutical Industries, Chemo Iberica, Maps Laboratories, Laurus Labs, Zhejiang Huahai Pharmaceutical, Vasudha Pharma Chem, Sun Pharmaceutical Industries, CTX Life Sciences, Srini Pharmaceuticals

What are the Application segmentation covered in the Pregabalin Market report?

Ans: The Applications covered in the Pregabalin Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Pregabalin Market report?

Ans: The Types covered in the Pregabalin Market report are Tablet, Capsule, Oral Solution

Recommended Reports

Pain & Nerve Drugs

Epilepsy & Anticonvulsants

Pain Management Therapies

1 Pregabalin Market Overview
1.1 Product Definition
1.2 Pregabalin by Type
1.2.1 Global Pregabalin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Oral Solution
1.3 Pregabalin by Application
1.3.1 Global Pregabalin Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Pregabalin Market Size Estimates and Forecasts
1.4.1 Global Pregabalin Revenue 2020-2031
1.4.2 Global Pregabalin Sales 2020-2031
1.4.3 Global Pregabalin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pregabalin Market Competition by Manufacturers
2.1 Global Pregabalin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pregabalin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pregabalin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pregabalin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pregabalin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pregabalin, Product Type & Application
2.7 Global Key Manufacturers of Pregabalin, Date of Enter into This Industry
2.8 Global Pregabalin Market Competitive Situation and Trends
2.8.1 Global Pregabalin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pregabalin Players Market Share by Revenue
2.8.3 Global Pregabalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pregabalin Market Scenario by Region
3.1 Global Pregabalin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pregabalin Sales by Region: 2020-2031
3.2.1 Global Pregabalin Sales by Region: 2020-2025
3.2.2 Global Pregabalin Sales by Region: 2026-2031
3.3 Global Pregabalin Revenue by Region: 2020-2031
3.3.1 Global Pregabalin Revenue by Region: 2020-2025
3.3.2 Global Pregabalin Revenue by Region: 2026-2031
3.4 North America Pregabalin Market Facts & Figures by Country
3.4.1 North America Pregabalin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pregabalin Sales by Country (2020-2031)
3.4.3 North America Pregabalin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pregabalin Market Facts & Figures by Country
3.5.1 Europe Pregabalin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pregabalin Sales by Country (2020-2031)
3.5.3 Europe Pregabalin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pregabalin Market Facts & Figures by Region
3.6.1 Asia Pacific Pregabalin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pregabalin Sales by Region (2020-2031)
3.6.3 Asia Pacific Pregabalin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pregabalin Market Facts & Figures by Country
3.7.1 Latin America Pregabalin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pregabalin Sales by Country (2020-2031)
3.7.3 Latin America Pregabalin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pregabalin Market Facts & Figures by Country
3.8.1 Middle East and Africa Pregabalin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pregabalin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pregabalin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pregabalin Sales by Type (2020-2031)
4.1.1 Global Pregabalin Sales by Type (2020-2025)
4.1.2 Global Pregabalin Sales by Type (2026-2031)
4.1.3 Global Pregabalin Sales Market Share by Type (2020-2031)
4.2 Global Pregabalin Revenue by Type (2020-2031)
4.2.1 Global Pregabalin Revenue by Type (2020-2025)
4.2.2 Global Pregabalin Revenue by Type (2026-2031)
4.2.3 Global Pregabalin Revenue Market Share by Type (2020-2031)
4.3 Global Pregabalin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pregabalin Sales by Application (2020-2031)
5.1.1 Global Pregabalin Sales by Application (2020-2025)
5.1.2 Global Pregabalin Sales by Application (2026-2031)
5.1.3 Global Pregabalin Sales Market Share by Application (2020-2031)
5.2 Global Pregabalin Revenue by Application (2020-2031)
5.2.1 Global Pregabalin Revenue by Application (2020-2025)
5.2.2 Global Pregabalin Revenue by Application (2026-2031)
5.2.3 Global Pregabalin Revenue Market Share by Application (2020-2031)
5.3 Global Pregabalin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ZCL Chemicals
6.1.1 ZCL Chemicals Company Information
6.1.2 ZCL Chemicals Description and Business Overview
6.1.3 ZCL Chemicals Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ZCL Chemicals Pregabalin Product Portfolio
6.1.5 ZCL Chemicals Recent Developments/Updates
6.2 Olon S.p.A.
6.2.1 Olon S.p.A. Company Information
6.2.2 Olon S.p.A. Description and Business Overview
6.2.3 Olon S.p.A. Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Olon S.p.A. Pregabalin Product Portfolio
6.2.5 Olon S.p.A. Recent Developments/Updates
6.3 AASraw Biochemical Technology
6.3.1 AASraw Biochemical Technology Company Information
6.3.2 AASraw Biochemical Technology Description and Business Overview
6.3.3 AASraw Biochemical Technology Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AASraw Biochemical Technology Pregabalin Product Portfolio
6.3.5 AASraw Biochemical Technology Recent Developments/Updates
6.4 Changzhou Pharmaceutical Factory (CPF)
6.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
6.4.2 Changzhou Pharmaceutical Factory (CPF) Description and Business Overview
6.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolio
6.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Developments/Updates
6.5 Almelo Pvt. Ltd.
6.5.1 Almelo Pvt. Ltd. Company Information
6.5.2 Almelo Pvt. Ltd. Description and Business Overview
6.5.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Almelo Pvt. Ltd. Pregabalin Product Portfolio
6.5.5 Almelo Pvt. Ltd. Recent Developments/Updates
6.6 Divi’s Laboratories
6.6.1 Divi’s Laboratories Company Information
6.6.2 Divi’s Laboratories Description and Business Overview
6.6.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Divi’s Laboratories Pregabalin Product Portfolio
6.6.5 Divi’s Laboratories Recent Developments/Updates
6.7 Angels Pharma
6.7.1 Angels Pharma Company Information
6.7.2 Angels Pharma Description and Business Overview
6.7.3 Angels Pharma Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Angels Pharma Pregabalin Product Portfolio
6.7.5 Angels Pharma Recent Developments/Updates
6.8 ARITE Pharmaceutical
6.8.1 ARITE Pharmaceutical Company Information
6.8.2 ARITE Pharmaceutical Description and Business Overview
6.8.3 ARITE Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ARITE Pharmaceutical Pregabalin Product Portfolio
6.8.5 ARITE Pharmaceutical Recent Developments/Updates
6.9 BAL Pharma
6.9.1 BAL Pharma Company Information
6.9.2 BAL Pharma Description and Business Overview
6.9.3 BAL Pharma Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BAL Pharma Pregabalin Product Portfolio
6.9.5 BAL Pharma Recent Developments/Updates
6.10 Bazayan
6.10.1 Bazayan Company Information
6.10.2 Bazayan Description and Business Overview
6.10.3 Bazayan Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bazayan Pregabalin Product Portfolio
6.10.5 Bazayan Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Company Information
6.11.2 Aurobindo Pharma Description and Business Overview
6.11.3 Aurobindo Pharma Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aurobindo Pharma Pregabalin Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Hikal
6.12.1 Hikal Company Information
6.12.2 Hikal Description and Business Overview
6.12.3 Hikal Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hikal Pregabalin Product Portfolio
6.12.5 Hikal Recent Developments/Updates
6.13 Glenmark Life Sciences
6.13.1 Glenmark Life Sciences Company Information
6.13.2 Glenmark Life Sciences Description and Business Overview
6.13.3 Glenmark Life Sciences Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Glenmark Life Sciences Pregabalin Product Portfolio
6.13.5 Glenmark Life Sciences Recent Developments/Updates
6.14 Dongbang FTL
6.14.1 Dongbang FTL Company Information
6.14.2 Dongbang FTL Description and Business Overview
6.14.3 Dongbang FTL Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dongbang FTL Pregabalin Product Portfolio
6.14.5 Dongbang FTL Recent Developments/Updates
6.15 Teva Pharmaceutical Industries
6.15.1 Teva Pharmaceutical Industries Company Information
6.15.2 Teva Pharmaceutical Industries Description and Business Overview
6.15.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Teva Pharmaceutical Industries Pregabalin Product Portfolio
6.15.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.16 Divi’s Laboratories
6.16.1 Divi’s Laboratories Company Information
6.16.2 Divi’s Laboratories Description and Business Overview
6.16.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Divi’s Laboratories Pregabalin Product Portfolio
6.16.5 Divi’s Laboratories Recent Developments/Updates
6.17 Chemo Iberica
6.17.1 Chemo Iberica Company Information
6.17.2 Chemo Iberica Description and Business Overview
6.17.3 Chemo Iberica Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Chemo Iberica Pregabalin Product Portfolio
6.17.5 Chemo Iberica Recent Developments/Updates
6.18 Maps Laboratories
6.18.1 Maps Laboratories Company Information
6.18.2 Maps Laboratories Description and Business Overview
6.18.3 Maps Laboratories Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Maps Laboratories Pregabalin Product Portfolio
6.18.5 Maps Laboratories Recent Developments/Updates
6.19 Laurus Labs
6.19.1 Laurus Labs Company Information
6.19.2 Laurus Labs Description and Business Overview
6.19.3 Laurus Labs Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Laurus Labs Pregabalin Product Portfolio
6.19.5 Laurus Labs Recent Developments/Updates
6.20 Zhejiang Huahai Pharmaceutical
6.20.1 Zhejiang Huahai Pharmaceutical Company Information
6.20.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.20.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolio
6.20.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.21 Vasudha Pharma Chem
6.21.1 Vasudha Pharma Chem Company Information
6.21.2 Vasudha Pharma Chem Description and Business Overview
6.21.3 Vasudha Pharma Chem Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Vasudha Pharma Chem Pregabalin Product Portfolio
6.21.5 Vasudha Pharma Chem Recent Developments/Updates
6.22 Sun Pharmaceutical Industries
6.22.1 Sun Pharmaceutical Industries Company Information
6.22.2 Sun Pharmaceutical Industries Description and Business Overview
6.22.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Sun Pharmaceutical Industries Pregabalin Product Portfolio
6.22.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.23 CTX Life Sciences
6.23.1 CTX Life Sciences Company Information
6.23.2 CTX Life Sciences Description and Business Overview
6.23.3 CTX Life Sciences Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.23.4 CTX Life Sciences Pregabalin Product Portfolio
6.23.5 CTX Life Sciences Recent Developments/Updates
6.24 Srini Pharmaceuticals
6.24.1 Srini Pharmaceuticals Company Information
6.24.2 Srini Pharmaceuticals Description and Business Overview
6.24.3 Srini Pharmaceuticals Pregabalin Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Srini Pharmaceuticals Pregabalin Product Portfolio
6.24.5 Srini Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pregabalin Industry Chain Analysis
7.2 Pregabalin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pregabalin Production Mode & Process Analysis
7.4 Pregabalin Sales and Marketing
7.4.1 Pregabalin Sales Channels
7.4.2 Pregabalin Distributors
7.5 Pregabalin Customer Analysis
8 Pregabalin Market Dynamics
8.1 Pregabalin Industry Trends
8.2 Pregabalin Market Drivers
8.3 Pregabalin Market Challenges
8.4 Pregabalin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pregabalin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pregabalin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pregabalin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pregabalin Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Pregabalin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pregabalin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pregabalin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pregabalin Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pregabalin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pregabalin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pregabalin, Product Type & Application
 Table 12. Global Key Manufacturers of Pregabalin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pregabalin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pregabalin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pregabalin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pregabalin Sales by Region (2020-2025) & (K MT)
 Table 18. Global Pregabalin Sales Market Share by Region (2020-2025)
 Table 19. Global Pregabalin Sales by Region (2026-2031) & (K MT)
 Table 20. Global Pregabalin Sales Market Share by Region (2026-2031)
 Table 21. Global Pregabalin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pregabalin Revenue Market Share by Region (2020-2025)
 Table 23. Global Pregabalin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pregabalin Revenue Market Share by Region (2026-2031)
 Table 25. North America Pregabalin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pregabalin Sales by Country (2020-2025) & (K MT)
 Table 27. North America Pregabalin Sales by Country (2026-2031) & (K MT)
 Table 28. North America Pregabalin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pregabalin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pregabalin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pregabalin Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Pregabalin Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Pregabalin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pregabalin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pregabalin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pregabalin Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Pregabalin Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Pregabalin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pregabalin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pregabalin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pregabalin Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Pregabalin Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Pregabalin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pregabalin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pregabalin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pregabalin Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Pregabalin Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Pregabalin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pregabalin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pregabalin Sales (K MT) by Type (2020-2025)
 Table 51. Global Pregabalin Sales (K MT) by Type (2026-2031)
 Table 52. Global Pregabalin Sales Market Share by Type (2020-2025)
 Table 53. Global Pregabalin Sales Market Share by Type (2026-2031)
 Table 54. Global Pregabalin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pregabalin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pregabalin Revenue Market Share by Type (2020-2025)
 Table 57. Global Pregabalin Revenue Market Share by Type (2026-2031)
 Table 58. Global Pregabalin Price (USD/MT) by Type (2020-2025)
 Table 59. Global Pregabalin Price (USD/MT) by Type (2026-2031)
 Table 60. Global Pregabalin Sales (K MT) by Application (2020-2025)
 Table 61. Global Pregabalin Sales (K MT) by Application (2026-2031)
 Table 62. Global Pregabalin Sales Market Share by Application (2020-2025)
 Table 63. Global Pregabalin Sales Market Share by Application (2026-2031)
 Table 64. Global Pregabalin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pregabalin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pregabalin Revenue Market Share by Application (2020-2025)
 Table 67. Global Pregabalin Revenue Market Share by Application (2026-2031)
 Table 68. Global Pregabalin Price (USD/MT) by Application (2020-2025)
 Table 69. Global Pregabalin Price (USD/MT) by Application (2026-2031)
 Table 70. ZCL Chemicals Company Information
 Table 71. ZCL Chemicals Description and Business Overview
 Table 72. ZCL Chemicals Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. ZCL Chemicals Pregabalin Product
 Table 74. ZCL Chemicals Recent Developments/Updates
 Table 75. Olon S.p.A. Company Information
 Table 76. Olon S.p.A. Description and Business Overview
 Table 77. Olon S.p.A. Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Olon S.p.A. Pregabalin Product
 Table 79. Olon S.p.A. Recent Developments/Updates
 Table 80. AASraw Biochemical Technology Company Information
 Table 81. AASraw Biochemical Technology Description and Business Overview
 Table 82. AASraw Biochemical Technology Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. AASraw Biochemical Technology Pregabalin Product
 Table 84. AASraw Biochemical Technology Recent Developments/Updates
 Table 85. Changzhou Pharmaceutical Factory (CPF) Company Information
 Table 86. Changzhou Pharmaceutical Factory (CPF) Description and Business Overview
 Table 87. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product
 Table 89. Changzhou Pharmaceutical Factory (CPF) Recent Developments/Updates
 Table 90. Almelo Pvt. Ltd. Company Information
 Table 91. Almelo Pvt. Ltd. Description and Business Overview
 Table 92. Almelo Pvt. Ltd. Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Almelo Pvt. Ltd. Pregabalin Product
 Table 94. Almelo Pvt. Ltd. Recent Developments/Updates
 Table 95. Divi’s Laboratories Company Information
 Table 96. Divi’s Laboratories Description and Business Overview
 Table 97. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Divi’s Laboratories Pregabalin Product
 Table 99. Divi’s Laboratories Recent Developments/Updates
 Table 100. Angels Pharma Company Information
 Table 101. Angels Pharma Description and Business Overview
 Table 102. Angels Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Angels Pharma Pregabalin Product
 Table 104. Angels Pharma Recent Developments/Updates
 Table 105. ARITE Pharmaceutical Company Information
 Table 106. ARITE Pharmaceutical Description and Business Overview
 Table 107. ARITE Pharmaceutical Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. ARITE Pharmaceutical Pregabalin Product
 Table 109. ARITE Pharmaceutical Recent Developments/Updates
 Table 110. BAL Pharma Company Information
 Table 111. BAL Pharma Description and Business Overview
 Table 112. BAL Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. BAL Pharma Pregabalin Product
 Table 114. BAL Pharma Recent Developments/Updates
 Table 115. Bazayan Company Information
 Table 116. Bazayan Description and Business Overview
 Table 117. Bazayan Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Bazayan Pregabalin Product
 Table 119. Bazayan Recent Developments/Updates
 Table 120. Aurobindo Pharma Company Information
 Table 121. Aurobindo Pharma Description and Business Overview
 Table 122. Aurobindo Pharma Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Aurobindo Pharma Pregabalin Product
 Table 124. Aurobindo Pharma Recent Developments/Updates
 Table 125. Hikal Company Information
 Table 126. Hikal Description and Business Overview
 Table 127. Hikal Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Hikal Pregabalin Product
 Table 129. Hikal Recent Developments/Updates
 Table 130. Glenmark Life Sciences Company Information
 Table 131. Glenmark Life Sciences Description and Business Overview
 Table 132. Glenmark Life Sciences Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. Glenmark Life Sciences Pregabalin Product
 Table 134. Glenmark Life Sciences Recent Developments/Updates
 Table 135. Dongbang FTL Company Information
 Table 136. Dongbang FTL Description and Business Overview
 Table 137. Dongbang FTL Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 138. Dongbang FTL Pregabalin Product
 Table 139. Dongbang FTL Recent Developments/Updates
 Table 140. Teva Pharmaceutical Industries Company Information
 Table 141. Teva Pharmaceutical Industries Description and Business Overview
 Table 142. Teva Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 143. Teva Pharmaceutical Industries Pregabalin Product
 Table 144. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 145. Divi’s Laboratories Company Information
 Table 146. Divi’s Laboratories Description and Business Overview
 Table 147. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 148. Divi’s Laboratories Pregabalin Product
 Table 149. Divi’s Laboratories Recent Developments/Updates
 Table 150. Chemo Iberica Company Information
 Table 151. Chemo Iberica Description and Business Overview
 Table 152. Chemo Iberica Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 153. Chemo Iberica Pregabalin Product
 Table 154. Chemo Iberica Recent Developments/Updates
 Table 155. Maps Laboratories Company Information
 Table 156. Maps Laboratories Description and Business Overview
 Table 157. Maps Laboratories Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 158. Maps Laboratories Pregabalin Product
 Table 159. Maps Laboratories Recent Developments/Updates
 Table 160. Laurus Labs Company Information
 Table 161. Laurus Labs Description and Business Overview
 Table 162. Laurus Labs Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 163. Laurus Labs Pregabalin Product
 Table 164. Laurus Labs Recent Developments/Updates
 Table 165. Zhejiang Huahai Pharmaceutical Company Information
 Table 166. Zhejiang Huahai Pharmaceutical Description and Business Overview
 Table 167. Zhejiang Huahai Pharmaceutical Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 168. Zhejiang Huahai Pharmaceutical Pregabalin Product
 Table 169. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
 Table 170. Vasudha Pharma Chem Company Information
 Table 171. Vasudha Pharma Chem Description and Business Overview
 Table 172. Vasudha Pharma Chem Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 173. Vasudha Pharma Chem Pregabalin Product
 Table 174. Vasudha Pharma Chem Recent Developments/Updates
 Table 175. Sun Pharmaceutical Industries Company Information
 Table 176. Sun Pharmaceutical Industries Description and Business Overview
 Table 177. Sun Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 178. Sun Pharmaceutical Industries Pregabalin Product
 Table 179. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 180. CTX Life Sciences Company Information
 Table 181. CTX Life Sciences Description and Business Overview
 Table 182. CTX Life Sciences Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 183. CTX Life Sciences Pregabalin Product
 Table 184. CTX Life Sciences Recent Developments/Updates
 Table 185. Srini Pharmaceuticals Company Information
 Table 186. Srini Pharmaceuticals Description and Business Overview
 Table 187. Srini Pharmaceuticals Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 188. Srini Pharmaceuticals Pregabalin Product
 Table 189. Srini Pharmaceuticals Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Pregabalin Distributors List
 Table 193. Pregabalin Customers List
 Table 194. Pregabalin Market Trends
 Table 195. Pregabalin Market Drivers
 Table 196. Pregabalin Market Challenges
 Table 197. Pregabalin Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pregabalin
 Figure 2. Global Pregabalin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pregabalin Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Oral Solution Product Picture
 Figure 7. Global Pregabalin Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pregabalin Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Others
 Figure 12. Global Pregabalin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pregabalin Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pregabalin Sales (2020-2031) & (K MT)
 Figure 15. Global Pregabalin Average Price (USD/MT) & (2020-2031)
 Figure 16. Pregabalin Report Years Considered
 Figure 17. Pregabalin Sales Share by Manufacturers in 2024
 Figure 18. Global Pregabalin Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pregabalin Players: Market Share by Revenue in Pregabalin in 2024
 Figure 20. Pregabalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pregabalin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pregabalin Sales Market Share by Country (2020-2031)
 Figure 23. North America Pregabalin Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pregabalin Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pregabalin Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pregabalin Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pregabalin Revenue Market Share by Region (2020-2031)
 Figure 35. China Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Pregabalin Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Pregabalin Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Pregabalin Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Pregabalin Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Pregabalin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Pregabalin by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Pregabalin by Type (2020-2031)
 Figure 57. Global Pregabalin Price (USD/MT) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Pregabalin by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Pregabalin by Application (2020-2031)
 Figure 60. Global Pregabalin Price (USD/MT) by Application (2020-2031)
 Figure 61. Pregabalin Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India